Skip to main content
PMC home page
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Nov 22.
Published in final edited form as: Cancer Metastasis Rev. 2016 Sep;35(3):489. doi: 10.1007/s10555-016-9627-z

Retraction

PMCID: PMC5118946  NIHMSID: NIHMS830190  PMID: 27239671

Retraction note to: Targeted immune therapy of ovarian cancer

Keith L. Knutson1,2,3 • Lavakumar Karyampudi1 • Purushottam Lamichhane1,2 • Claudia Preston2

Retraction Note to: Cancer Metastasis Rev (2015) 34:53–74 DOI 10.1007/s10555-014-9540-2

This article has been retracted at the request of the authors and in agreement with the Editors in Chief. The article contains large portions of text that have been duplicated from the articles:

  1. Immunity and immune suppression in human ovarian cancer Claudia C Preston, Ellen L Goode, Lynn C Hartmann, Kimberly R Kalli, and Keith L Knutson Immunotherapy. 2011 Apr. 3(4): 539–556, DOI 10.2217/imt.11.20

  2. The Immune System in the Pathogenesis of Ovarian Cancer Bridget Charbonneau, Ellen L. Goode, Kimberly R. Kalli, Keith L. Knutson, and Melissa S. DeRycke Crit Rev Immunol. 2013; 33(2): 137–164, DOI: 10.1615/CritRevImmunol.2013006813

The authors would like to express their most sincere apology to the editors and readers of the journal.

The online version of the original article can be found at http://dx.doi.org/10.1007/s10555-014-9540-2.

* Keith L. Knutson

kknutson@vgtifl.org

1 Cancer Vaccines and Immune Therapies Program, The Vaccine and Gene Therapy Institute of Florida, Port St. Lucie, FL 34949, USA

2 Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA

3 Center for Molecular Biology and Biotechnology (CMBB), Florida Atlantic University, Boca Raton, FL 33431, USA

RESOURCES